UNCY
UNCY
NASDAQ · Biotechnology

Unicycive Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$3.64
-0.14 (-3.70%)
As of Nov 14, 2:22 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +72.3% upside
Low Target $3.63
Average Target $6.27
High Target $7.20
Current Price $3.64
Current
$3.64
Target
$6.27
$3.63 $6.27 avg $7.20
Scenario Analysis
Bear Case
$3.63
-0.3%
Low target
Base Case
$6.27
+72.3%
Avg target
Bull Case
$7.20
+97.8%
High target
Risk/Reward
356.0x
Highly favorable
Price in Context
52-Week High
$8.74
-58.4% from high
52-Week Low
$3.33
+9.3% from low
Target vs 52W High
$6.27
-28.3% vs high
Next Earnings Report
Nov 18, 2026
3d
until earnings
EPS Est: $-0.32
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -33.8%